These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 11265283)
21. Multiple solvent crystal structures of ribonuclease A: an assessment of the method. Dechene M; Wink G; Smith M; Swartz P; Mattos C Proteins; 2009 Sep; 76(4):861-81. PubMed ID: 19291738 [TBL] [Abstract][Full Text] [Related]
23. Cytotoxicity of bovine seminal ribonuclease: monomer versus dimer. Lee JE; Raines RT Biochemistry; 2005 Dec; 44(48):15760-7. PubMed ID: 16313179 [TBL] [Abstract][Full Text] [Related]
24. Using proton nuclear magnetic resonance to study the mode of ribonuclease A inhibition by competitive and noncompetitive inhibitors. Ghosh KS; Debnath J; Pathak T; Dasgupta S Bioorg Med Chem Lett; 2008 Oct; 18(20):5503-6. PubMed ID: 18812256 [TBL] [Abstract][Full Text] [Related]
25. A nuclear localization sequence endows human pancreatic ribonuclease with cytotoxic activity. Bosch M; Benito A; Ribó M; Puig T; Beaumelle B; Vilanova M Biochemistry; 2004 Mar; 43(8):2167-77. PubMed ID: 14979713 [TBL] [Abstract][Full Text] [Related]
26. Increasing protein crystallization screening success with heterogeneous nucleating agents. Thakur AS; Newman J; Martin JL; Kobe B Methods Mol Biol; 2008; 426():403-9. PubMed ID: 18542879 [TBL] [Abstract][Full Text] [Related]
27. Development of selective RabGGTase inhibitors and crystal structure of a RabGGTase-inhibitor complex. Guo Z; Wu YW; Tan KT; Bon RS; Guiu-Rozas E; Delon C; Nguyen TU; Wetzel S; Arndt S; Goody RS; Blankenfeldt W; Alexandrov K; Waldmann H Angew Chem Int Ed Engl; 2008; 47(20):3747-50. PubMed ID: 18399557 [No Abstract] [Full Text] [Related]
28. Green tea polyphenols as inhibitors of ribonuclease A. Ghosh KS; Maiti TK; Dasgupta S Biochem Biophys Res Commun; 2004 Dec; 325(3):807-11. PubMed ID: 15541362 [TBL] [Abstract][Full Text] [Related]
29. Structure determination of GGA-GAE and gamma1-ear in complex with peptides: crystallization of low-affinity complexes in membrane traffic. Yamada Y; Inoue M; Shiba T; Kawasaki M; Kato R; Nakayama K; Wakatsuki S Acta Crystallogr D Biol Crystallogr; 2005 Jun; 61(Pt 6):731-6. PubMed ID: 15930630 [TBL] [Abstract][Full Text] [Related]
30. Higher-throughput approaches to crystallization and crystal structure determination. Fogg MJ; Wilkinson AJ Biochem Soc Trans; 2008 Aug; 36(Pt 4):771-5. PubMed ID: 18631156 [TBL] [Abstract][Full Text] [Related]
31. Comparisons of NMR spectral quality and success in crystallization demonstrate that NMR and X-ray crystallography are complementary methods for small protein structure determination. Snyder DA; Chen Y; Denissova NG; Acton T; Aramini JM; Ciano M; Karlin R; Liu J; Manor P; Rajan PA; Rossi P; Swapna GV; Xiao R; Rost B; Hunt J; Montelione GT J Am Chem Soc; 2005 Nov; 127(47):16505-11. PubMed ID: 16305237 [TBL] [Abstract][Full Text] [Related]
32. High-resolution crystal structure of manganese peroxidase: substrate and inhibitor complexes. Sundaramoorthy M; Youngs HL; Gold MH; Poulos TL Biochemistry; 2005 May; 44(17):6463-70. PubMed ID: 15850380 [TBL] [Abstract][Full Text] [Related]
33. Crystal structure of archaeal ribonuclease P protein aRpp29 from Archaeoglobus fulgidus. Sidote DJ; Heideker J; Hoffman DW Biochemistry; 2004 Nov; 43(44):14128-38. PubMed ID: 15518563 [TBL] [Abstract][Full Text] [Related]
34. Functional evolution of ribonuclease inhibitor: insights from birds and reptiles. Lomax JE; Bianchetti CM; Chang A; Phillips GN; Fox BG; Raines RT J Mol Biol; 2014 Aug; 426(17):3041-56. PubMed ID: 24941155 [TBL] [Abstract][Full Text] [Related]
35. Protein crystal growth in microgravity-temperature induced large scale crystallization of insulin. Long MM; DeLucas LJ; Smith C; Carson M; Moore K; Harrington MD; Pillion DJ; Bishop SP; Rosenblum WM; Naumann RJ; Chait A; Prahl J; Bugg CE Microgravity Sci Technol; 1994 Jul; 7(2):196-202. PubMed ID: 11541852 [TBL] [Abstract][Full Text] [Related]
36. Tandemization endows bovine pancreatic ribonuclease with cytotoxic activity. Leich F; Köditz J; Ulbrich-Hofman R; Arnold U J Mol Biol; 2006 May; 358(5):1305-13. PubMed ID: 16580680 [TBL] [Abstract][Full Text] [Related]
37. Interactions of gold-based drugs with proteins: crystal structure of the adduct formed between ribonuclease A and a cytotoxic gold(III) compound. Messori L; Scaletti F; Massai L; Cinellu MA; Russo Krauss I; di Martino G; Vergara A; Paduano L; Merlino A Metallomics; 2014 Feb; 6(2):233-6. PubMed ID: 24287583 [TBL] [Abstract][Full Text] [Related]
38. Structural insights into the human and avian IMP cyclohydrolase mechanism via crystal structures with the bound XMP inhibitor. Wolan DW; Cheong CG; Greasley SE; Wilson IA Biochemistry; 2004 Feb; 43(5):1171-83. PubMed ID: 14756553 [TBL] [Abstract][Full Text] [Related]
39. Total synthesis by modern chemical ligation methods and high resolution (1.1 A) X-ray structure of ribonuclease A. Boerema DJ; Tereshko VA; Kent SB Biopolymers; 2008; 90(3):278-86. PubMed ID: 17610259 [TBL] [Abstract][Full Text] [Related]
40. Nucleant-mediated protein crystallization with the application of microporous synthetic zeolites. Sugahara M; Asada Y; Morikawa Y; Kageyama Y; Kunishima N Acta Crystallogr D Biol Crystallogr; 2008 Jun; 64(Pt 6):686-95. PubMed ID: 18560157 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]